Rajiv Narang

3.0k total citations
99 papers, 1.9k citations indexed

About

Rajiv Narang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rajiv Narang has authored 99 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 21 papers in Surgery and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rajiv Narang's work include Cardiac Valve Diseases and Treatments (8 papers), Cardiovascular Function and Risk Factors (8 papers) and Blood Pressure and Hypertension Studies (8 papers). Rajiv Narang is often cited by papers focused on Cardiac Valve Diseases and Treatments (8 papers), Cardiovascular Function and Risk Factors (8 papers) and Blood Pressure and Hypertension Studies (8 papers). Rajiv Narang collaborates with scholars based in India, United States and United Kingdom. Rajiv Narang's co-authors include Kamna Srivastava, Daman Saluja, Jagriti Bhatia, John G.F. Cleland, Vishnubhatla Sreenivas, Dinesh Khandelwal, Vikas Gulati, Ashish Goel, Karl Swedberg and K.K. Talwar and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Rajiv Narang

87 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rajiv Narang India 22 712 314 268 232 224 99 1.9k
Ingrid Hopper Australia 26 875 1.2× 686 2.2× 331 1.2× 150 0.6× 106 0.5× 104 2.1k
W. David Strain United Kingdom 27 789 1.1× 382 1.2× 771 2.9× 290 1.3× 409 1.8× 117 2.6k
Yi‐Tong Ma China 23 1.1k 1.5× 423 1.3× 277 1.0× 330 1.4× 155 0.7× 98 3.6k
Yuqing Zhang China 25 1.1k 1.5× 273 0.9× 277 1.0× 199 0.9× 121 0.5× 120 2.4k
Joško Božić Croatia 23 283 0.4× 312 1.0× 169 0.6× 358 1.5× 346 1.5× 174 1.9k
Andrew Ignaszewski Canada 25 1.4k 1.9× 493 1.6× 256 1.0× 134 0.6× 396 1.8× 86 2.7k
Manlu Zhu China 14 969 1.4× 189 0.6× 294 1.1× 179 0.8× 316 1.4× 30 2.2k
Philip Joseph Canada 20 790 1.1× 301 1.0× 194 0.7× 313 1.3× 154 0.7× 51 2.0k
Young Hoon Lee South Korea 26 508 0.7× 267 0.9× 311 1.2× 282 1.2× 370 1.7× 174 2.4k
Camelia Cristina Diaconu Romania 30 371 0.5× 563 1.8× 320 1.2× 385 1.7× 234 1.0× 286 2.6k

Countries citing papers authored by Rajiv Narang

Since Specialization
Citations

This map shows the geographic impact of Rajiv Narang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajiv Narang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajiv Narang more than expected).

Fields of papers citing papers by Rajiv Narang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajiv Narang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajiv Narang. The network helps show where Rajiv Narang may publish in the future.

Co-authorship network of co-authors of Rajiv Narang

This figure shows the co-authorship network connecting the top 25 collaborators of Rajiv Narang. A scholar is included among the top collaborators of Rajiv Narang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajiv Narang. Rajiv Narang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Handa, Ankur, Sudip Kumar Datta, Sandeep Seth, et al.. (2025). Dapagliflozin in pediatric heart failure with reduced ejection fraction – A randomized pilot study. Annals of Pediatric Cardiology. 18(4). 323–330.
3.
Gupta, Gaurav, Surabhi Vyas, Shivam Pandey, et al.. (2023). Cardiopulmonary Outcomes in Covid-19 Patients Discharged From a Tertiary Care Center: A Prospective Study. National Academy Science Letters. 46(6). 571–578. 1 indexed citations
4.
5.
6.
Mathew, Roshan, et al.. (2021). Utility of HEART Pathway in Identifying Low-Risk Chest Pain in Emergency Department. Journal of Emergency Medicine. 60(4). 421–427. 2 indexed citations
7.
Kumar, Arun, et al.. (2020). Impact of bariatric surgery on carotid intima-medial thickness and cardiovascular risk: results of a prospective study. Surgical Endoscopy. 35(11). 6006–6012. 12 indexed citations
8.
Saxena, Anitá, et al.. (2016). Successful Percutaneous Device Closure of Right Ventricular Perforation During Pericardiocentesis. JACC: Cardiovascular Interventions. 9(22). e221–e222. 3 indexed citations
9.
Srivastava, Kamna, Sudhir Chandra, Jagriti Bhatia, Rajiv Narang, & Daman Saluja. (2012). Association of Angiotensinogen (M235T) Gene Polymorphism with Blood Pressure Lowering Response to Angiotensin Converting Enzyme Inhibitor (Enalapril). Journal of Pharmacy & Pharmaceutical Sciences. 15(3). 399–399. 18 indexed citations
10.
11.
Ballal, Sanjana, Chetan Patel, Suhas Singla, et al.. (2012). Comparison of software programs for the assessment of left ventricular ejection fraction using 99mTc-tetrofosmin-gated SPECT/CT. Nuclear Medicine Communications. 33(11). 1160–1168. 2 indexed citations
12.
Malik, Salma, Saurabh Bharti, Saroj Nepal, et al.. (2011). In Vivo Cardioprotection by Pitavastatin From Ischemic-reperfusion Injury Through Suppression of IKK/NF-κB and Upregulation of pAkt–e-NOS. Journal of Cardiovascular Pharmacology. 58(2). 199–206. 20 indexed citations
13.
Ramakrishnan, Sivasubramanian, Ambuj Roy, Lakshmy Ramakrishnan, et al.. (2011). Acute Effects of Tobacco Chewing on the Systemic, Pulmonary and Coronary Circulation. American Journal of Cardiovascular Drugs. 11(2). 109–114. 10 indexed citations
14.
Narang, Rajiv, D.S. Chadha, Kashish Goel, et al.. (2009). Screening coronary angiography prior to surgery in rheumatic valvular heart disease: a study of 2,188 patients.. PubMed. 18(4). 455–60. 11 indexed citations
15.
Narang, Rajiv, et al.. (2004). Low-density lipoprotein cholesterol estimation by a new formula in Indian population. International Journal of Cardiology. 102(1). 117–120. 102 indexed citations
16.
Agarwal, D. P., Kalpana Luthra, Rajiv Narang, et al.. (2003). Study of apolipoproteinc3 Sstl polymorphism in healthy volunteers from Northern India. Indian Journal of Clinical Biochemistry. 18(2). 34–38. 2 indexed citations
17.
Narang, Rajiv, et al.. (2002). Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians. BMC Genetics. 3(1). 9–9. 37 indexed citations
18.
Narang, Rajiv, et al.. (1997). Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. International Journal of Cardiology. 60(1). 73–79. 64 indexed citations
19.
Narang, Rajiv, et al.. (1974). Giant congenital cyst of the liver. Journal of Pediatric Surgery. 9(4). 561–562. 9 indexed citations
20.
Narang, Rajiv. (1962). Role of sodium estrone sulfate (Premarin) in hemoptysis.. PubMed. 85. 436–436.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ingrid Hopper Breakdown of academic impact, for papers by W. David Strain Breakdown of academic impact, for papers by Yi‐Tong Ma Breakdown of academic impact, for papers by Yuqing Zhang Breakdown of academic impact, for papers by Joško Božić Breakdown of academic impact, for papers by Andrew Ignaszewski Breakdown of academic impact, for papers by Manlu Zhu Breakdown of academic impact, for papers by Philip Joseph Breakdown of academic impact, for papers by Young Hoon Lee Breakdown of academic impact, for papers by Camelia Cristina Diaconu
Rankless by CCL
2026